Piper Sandler analyst Michael Lavery says an unfavorable currency exchange rate, softer than expected beer sales, and some lost distribution for hemp foods are weighing on Tilray’s sales momentum in fiscal Q2. Market share in Canadian recreation use appears to be stabilizing, though the company remains well below its mid-teens share from a year ago and price compression remains a headwind, Lavery tells investors in a research note. He reduced sales estimates to better reflect softer U.S. beer sales, which he says are trending worse than expected, especially Sweetwater’s launch in California. Lavery keeps a Neutral rating on Tilray shares with a $3 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TLRY:
- FDA explores regulating CBD in foods, supplements, WSJ reports
- Tilray Brands, Inc. to Announce Second Quarter Fiscal 2023 Financial Results on January 9, 2023
- Cannabis Stocks Sink on Exclusion of SAFE Banking Act from Spending Bill
- Unusually active option classes on open December 16th
- Tilray announces limited-edition, premium craft flower series by RIFF